Mark Thompson

Development of a PIV-vectored RSV vaccine: preclinical evaluation of safety, toxicity, and enhanced disease and initial clinical testing in healthy adults.

R. Walker, K. Reisinger, G. Losonsky, 2008, Vaccine.